Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $5,872 - $6,397
-117 Reduced 37.5%
195 $10,000
Q2 2023

Aug 09, 2023

BUY
$49.72 - $54.64 $2,038 - $2,240
41 Added 15.13%
312 $16,000
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $2,164 - $2,401
48 Added 21.52%
271 $13,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $2,093 - $2,467
55 Added 32.74%
223 $9,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $783 - $871
19 Added 12.75%
168 $7,000
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $5,748 - $6,591
149 New
149 $6,000
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $1.01 Million - $1.21 Million
-26,698 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $291,521 - $314,230
7,232 Added 37.15%
26,698 $1.09 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $679,558 - $836,648
19,466 New
19,466 $837,000
Q1 2019

May 10, 2019

SELL
$32.91 - $40.75 $494,538 - $612,350
-15,027 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $476,806 - $586,654
15,027 New
15,027 $531,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.